Bousquet J
*, Antó JM, Wickman M, Keil T, Valenta R, Haahtela T, Lodrup-Carlsen K, van Hage M, Akdis CA, Bachert C, Akdis M, Auffray C, Annesi-Maesano I, Bindslev-Jensen C, Cambon-Thomsen A, Carlsen KH, Chatzi L, Forastiere F, Garcia-Aymerich J, Gehring U, Guerra S, Heinrich J, Koppelman GH, Kowalski ML, Lambrecht B, Lupinek C, Maier D, Melen E, Momas I, Palkonen S, Pinart M, Postma DS, Siroux V, Smit HA, Sunyer J, Wright J, Zuberbier T, Arshad SH, Nadif R, Thijs C, Anderson N, Arsanoj A, Balardini N, Ballereau S, Bedbrook A, Benet M, Bergström A, Brunekreef B, Burte E, Calderon M, De Carlo G, Demoly P, Eller E, Fantini MP, Hammad H, Hohmann C, Just J, Kerkhof M, Kogevinas M, Kull I, Lau S, Lemonnier N, Mommers M, Nawijn MC, Nueubauer A, Oddie S, Pellet J, Pin I, Porta D, Saes Y, Skrindo I, Tischer C, Torrent M, von Hertzen L.
Are allergic multimorbidities and IgE polysensitization associated with the persistence or re-occurrence of foetal Type 2 signalling? The MeDALL hypothesis. Allergy 2015; 70(9): 1062-1078.